Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 637

1.

Dual Illumination Enhances Transformation of an Engineered Green-to-Red Photoconvertible Fluorescent Protein.

Krueger TD, Tang L, Zhu L, Breen IL, Wachter RM, Fang C.

Angew Chem Int Ed Engl. 2019 Nov 6. doi: 10.1002/anie.201911379. [Epub ahead of print]

PMID:
31692171
2.

Ethics in Conflict: Moral Distress as a Root Cause of Burnout.

Dzeng E, Wachter RM.

J Gen Intern Med. 2019 Oct 30. doi: 10.1007/s11606-019-05505-6. [Epub ahead of print] No abstract available.

PMID:
31667744
3.

Atrial fibrillation is frequent but does not affect risk stratification in pulmonary embolism.

Ebner M, Rogge NIJ, Parwani AS, Sentler C, Lerchbaumer MH, Pieske B, Konstantinides SV, Hasenfuß G, Wachter R, Lankeit M.

J Intern Med. 2019 Oct 11. doi: 10.1111/joim.12985. [Epub ahead of print]

PMID:
31602725
4.

Patient safety movement in neurological surgery: the current state and future directions.

Sankaran S, Andrews JP, Chicas M, Wachter RM, Berger MS.

J Neurosurg. 2019 Oct 4:1-11. doi: 10.3171/2019.7.JNS191505. [Epub ahead of print] No abstract available.

PMID:
31585429
5.

Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: Results of a randomised feasibility study.

Bosselmann L, Fangauf SV, Herbeck Belnap B, Chavanon ML, Nagel J, Neitzel C, Schertz A, Hummers E, Wachter R, Herrmann-Lingen C.

Eur J Cardiovasc Nurs. 2019 Sep 28:1474515119880062. doi: 10.1177/1474515119880062. [Epub ahead of print]

PMID:
31564125
6.

NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.

Uphaus T, Bittner S, Gröschel S, Steffen F, Muthuraman M, Wasser K, Weber-Krüger M, Zipp F, Wachter R, Gröschel K.

Stroke. 2019 Nov;50(11):3077-3084. doi: 10.1161/STROKEAHA.119.026410. Epub 2019 Sep 20.

PMID:
31537188
7.

Integrating Health Care Technologies: Challenges and Lessons Learned from One Medical Center's Experience.

Gupta K, Wachter RM.

Jt Comm J Qual Patient Saf. 2019 Oct;45(10):647-648. doi: 10.1016/j.jcjq.2019.07.010. Epub 2019 Aug 25. No abstract available.

PMID:
31462393
8.

Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT Neo system.

Wallbach M, Born E, Kämpfer D, Lüders S, Müller GA, Wachter R, Koziolek MJ.

Clin Res Cardiol. 2019 Aug 6. doi: 10.1007/s00392-019-01536-5. [Epub ahead of print]

PMID:
31388741
9.

Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression.

Fangauf SV, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Söllner W, Wachter R, Weber CS, Herrmann-Lingen C; SPIRR-CAD group.

J Psychosom Res. 2019 Aug;123:109728. doi: 10.1016/j.jpsychores.2019.05.006. Epub 2019 May 21.

PMID:
31376874
10.

Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients.

Diekmann S, Hörster L, Evers S, Hiligsmann M, Gelbrich G, Gröschel K, Wachter R, Hamann GF, Kermer P, Liman J, Weber-Krüger M; Find-AFRANDOMISED Investigators and Coordinators, Wasem J, Neumann A.

Curr Med Res Opin. 2019 Nov;35(11):1859-1866. doi: 10.1080/03007995.2019.1646000. Epub 2019 Aug 26.

PMID:
31315471
11.

Promoting Trust Between Patients and Physicians in the Era of Artificial Intelligence.

Nundy S, Montgomery T, Wachter RM.

JAMA. 2019 Jul 15. doi: 10.1001/jama.2018.20563. [Epub ahead of print] No abstract available.

PMID:
31305873
12.

Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study).

Verma A, Wachter R, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Kaplon RE, Ziegler PD, Sherfesee L, Reiffel JA.

Am J Cardiol. 2019 Sep 15;124(6):864-870. doi: 10.1016/j.amjcard.2019.06.006. Epub 2019 Jun 24.

PMID:
31303247
13.

Six habits of highly successful health information technology: powerful strategies for design and implementation.

Ray JM, Ratwani RM, Sinsky CA, Frankel RM, Friedberg MW, Powsner SM, Rosenthal DI, Wachter RM, Melnick ER.

J Am Med Inform Assoc. 2019 Oct 1;26(10):1109-1114. doi: 10.1093/jamia/ocz098.

PMID:
31265064
14.

Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.

Haarmann H, Koch J, Bonsch N, Mende M, Werhahn SM, Lüers C, Stahrenberg R, Edelmann F, Holzendorf V, von Haehling S, Pieske B, Andreas S, Lüthje L, Wachter R.

Respir Med. 2019 Jul - Aug;154:127-132. doi: 10.1016/j.rmed.2019.06.019. Epub 2019 Jun 21.

PMID:
31252205
15.

Reimagining Specialty Consultation in the Digital Age: The Potential Role of Targeted Automatic Electronic Consultations.

Wachter RM, Judson TJ, Mourad M.

JAMA. 2019 Jun 27. doi: 10.1001/jama.2019.6607. [Epub ahead of print] No abstract available.

PMID:
31246233
16.

Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.

Tsivgoulis G, Katsanos AH, Grory BM, Köhrmann M, Ricci BA, Tsioufis K, Cutting S, Krogias C, Schellinger PD, Campello AR, Cuadrado-Godia E, Gladstone DJ, Sanna T, Wachter R, Furie K, Alexandrov AV, Yaghi S.

Stroke. 2019 Aug;50(8):2175-2180. doi: 10.1161/STROKEAHA.119.025169. Epub 2019 Jun 20.

PMID:
31216964
17.

Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.

Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bøhmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noè A, Schwende H, Bao W, Butylin D, Pascual-Figal D; TRANSITION Investigators.

Eur J Heart Fail. 2019 Aug;21(8):998-1007. doi: 10.1002/ejhf.1498. Epub 2019 May 27.

18.

Artificial Intelligence in Health Care: Will the Value Match the Hype?

Emanuel EJ, Wachter RM.

JAMA. 2019 Jun 18;321(23):2281-2282. doi: 10.1001/jama.2019.4914. No abstract available.

PMID:
31107500
19.

Restricting the Number of Open Patient Records in the Electronic Health Record: Is the Record Half Open or Half Closed?

Wachter RM, Murray SG, Adler-Milstein J.

JAMA. 2019 May 14;321(18):1771-1773. doi: 10.1001/jama.2019.3835. No abstract available.

PMID:
31087007
20.

The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial.

Wasser K, Weber-Krüger M, Jürries F, Liman J, Hamann GF, Kermer P, Uphaus T, Protsenko E, Seegers J, Mende M, Gröschel K, Wachter R.

PLoS One. 2019 May 9;14(5):e0216530. doi: 10.1371/journal.pone.0216530. eCollection 2019.

21.

[Embolic stroke of undetermined source (ESUS) : How much monitoring is necessary?]

Stegmann T, Wachter R, Schäbitz WR.

Herz. 2019 Jun;44(4):289-295. doi: 10.1007/s00059-019-4805-8. German.

PMID:
31062047
22.

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction.

Bahls M, Friedrich N, Pietzner M, Wachter R, Budde K, Hasenfuß G, Nauck M, Pressler A, Felix SB, Edelmann F, Halle M, Dörr M.

J Clin Med. 2019 Apr 29;8(5). pii: E591. doi: 10.3390/jcm8050591.

23.

Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany.

Wachter R, Fonseca AF, Balas B, Kap E, Engelhard J, Schlienger R, Klebs S, Wirta SB, Kostev K.

Eur J Heart Fail. 2019 May;21(5):588-597. doi: 10.1002/ejhf.1465. Epub 2019 Apr 11.

24.

Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study.

Schertz A, Herbeck Belnap B, Chavanon ML, Edelmann F, Wachter R, Herrmann-Lingen C.

ESC Heart Fail. 2019 Aug;6(4):658-666. doi: 10.1002/ehf2.12436. Epub 2019 Apr 8.

25.

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.

Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Düngen HD, Angermann CE, Hasenfuß G, Pieske B, Wachter R, Edelmann F.

ESC Heart Fail. 2019 Apr;6(2):262-270. doi: 10.1002/ehf2.12413. Epub 2019 Feb 19.

26.

Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study.

Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C.

Psychoneuroendocrinology. 2019 Mar;101:272-277. doi: 10.1016/j.psyneuen.2018.12.230. Epub 2018 Dec 20.

PMID:
30594111
27.

Development and validation of a score to detect paroxysmal atrial fibrillation after stroke.

Uphaus T, Weber-Krüger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Gröschel K.

Neurology. 2019 Jan 8;92(2):e115-e124. doi: 10.1212/WNL.0000000000006727. Epub 2018 Dec 7.

PMID:
30530796
28.

Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.

Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF.

Int J Cardiol. 2018 Dec 1;272S:53-62. doi: 10.1016/j.ijcard.2018.08.080. Epub 2018 Aug 27. Review.

PMID:
30527996
29.

Assembly-disassembly is coupled to the ATPase cycle of tobacco Rubisco activase.

Serban AJ, Breen IL, Bui HQ, Levitus M, Wachter RM.

J Biol Chem. 2018 Dec 14;293(50):19451-19465. doi: 10.1074/jbc.RA118.005047. Epub 2018 Oct 23.

PMID:
30352875
30.

Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension.

Wallbach M, Zürbig P, Dihazi H, Müller GA, Wachter R, Beige J, Koziolek MJ, Mischak H.

J Clin Hypertens (Greenwich). 2018 Oct;20(10):1519-1526. doi: 10.1111/jch.13365. Epub 2018 Sep 10.

31.

[Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].

Wallbach M, Koziolek MJ, Wachter R.

Internist (Berl). 2018 Oct;59(10):1011-1020. doi: 10.1007/s00108-018-0488-0. Review. German.

PMID:
30182192
32.

Transforming concepts in patient safety: a progress report.

Gandhi TK, Kaplan GS, Leape L, Berwick DM, Edgman-Levitan S, Edmondson A, Meyer GS, Michaels D, Morath JM, Vincent C, Wachter R.

BMJ Qual Saf. 2018 Dec;27(12):1019-1026. doi: 10.1136/bmjqs-2017-007756. Epub 2018 Jul 17. Review.

33.

Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients.

Fangauf SV, Herbeck Belnap B, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Söllner W, Wachter R, Weber CS, Herrmann-Lingen C; SPIRR-CAD study group.

Psychoneuroendocrinology. 2018 Oct;96:188-194. doi: 10.1016/j.psyneuen.2018.06.001. Epub 2018 Jun 4.

PMID:
29982099
34.

Two Randomised Clinical Trials on the Use of Bryophyllum pinnatum in Preterm Labour: Results after Early Discontinuation.

Simões-Wüst AP, Lapaire O, Hösli I, Wächter R, Fürer K, Schnelle M, Mennet-von Eiff M, Seifert B, von Mandach U.

Complement Med Res. 2018;25(4):269-273. doi: 10.1159/000487431. Epub 2018 Jun 22. No abstract available.

PMID:
29945146
35.

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).

Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.

ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22. Erratum in: ESC Heart Fail. 2018 Dec;5(6):1199.

36.

Resolving the Productivity Paradox of Health Information Technology: A Time for Optimism.

Wachter RM, Howell MD.

JAMA. 2018 Jul 3;320(1):25-26. doi: 10.1001/jama.2018.5605. No abstract available.

PMID:
29813165
37.

Cross-Sectional and Longitudinal Associations of Systolic Blood Pressure With Quality of Life and Depressive Mood in Older Adults With Cardiovascular Risk Factors: Results From the Observational DIAST-CHF Study.

Herrmann-Lingen C, Meyer T, Bosbach A, Chavanon ML, Hassoun L, Edelmann F, Wachter R.

Psychosom Med. 2018 Jun;80(5):468-474. doi: 10.1097/PSY.0000000000000591.

PMID:
29742752
38.

Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.

Ravassa S, Trippel T, Bach D, Bachran D, González A, López B, Wachter R, Hasenfuss G, Delles C, Dominiczak AF, Pieske B, Díez J, Edelmann F.

Eur J Heart Fail. 2018 Sep;20(9):1290-1299. doi: 10.1002/ejhf.1194. Epub 2018 Apr 30.

39.

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.

Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R; TEAM in AF group.

Int J Cardiol. 2018 Aug 15;265:141-147. doi: 10.1016/j.ijcard.2018.04.093. Epub 2018 Apr 22.

PMID:
29706429
40.

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J.

Int J Cardiol. 2018 Sep 1;266:187-192. doi: 10.1016/j.ijcard.2018.04.075. Epub 2018 Apr 21.

PMID:
29705650
41.

Expert opinion paper on atrial fibrillation detection after ischemic stroke.

Haeusler KG, Gröschel K, Köhrmann M, Anker SD, Brachmann J, Böhm M, Diener HC, Doehner W, Endres M, Gerloff C, Huttner HB, Kaps M, Kirchhof P, Nabavi DG, Nolte CH, Pfeilschifter W, Pieske B, Poli S, Schäbitz WR, Thomalla G, Veltkamp R, Steiner T, Laufs U, Röther J, Wachter R, Schnabel R.

Clin Res Cardiol. 2018 Oct;107(10):871-880. doi: 10.1007/s00392-018-1256-9. Epub 2018 Apr 27. Review.

PMID:
29704214
42.

Safety profile of baroreflex activation therapy (NEO) in patients with resistant hypertension.

Wallbach M, Böhning E, Lehnig LY, Schroer C, Müller GA, Wachter R, Lüders S, Zenker D, Koziolek MJ.

J Hypertens. 2018 Aug;36(8):1762-1769. doi: 10.1097/HJH.0000000000001753.

PMID:
29677053
43.

Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.

Baldassarri F, Schwedhelm E, Atzler D, Böger RH, Cordts K, Haller B, Pressler A, Müller S, Suchy C, Wachter R, Düngen HD, Hasenfuss G, Pieske B, Halle M, Edelmann F, Duvinage A.

Biomarkers. 2018 Sep;23(6):540-550. doi: 10.1080/1354750X.2018.1460762. Epub 2018 Apr 12.

PMID:
29619838
44.

Single-molecule diffusometry reveals the nucleotide-dependent oligomerization pathways of Nicotiana tabacum Rubisco activase.

Wang Q, Serban AJ, Wachter RM, Moerner WE.

J Chem Phys. 2018 Mar 28;148(12):123319. doi: 10.1063/1.5005930.

PMID:
29604852
45.

[Atrial fibrillation as a comorbidity of heart failure].

Wachter R.

Internist (Berl). 2018 May;59(5):415-419. doi: 10.1007/s00108-018-0411-8. Review. German.

PMID:
29600336
46.

Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.

Hellenkamp K, Pruszczyk P, Jiménez D, Wyzgał A, Barrios D, Ciurzyński M, Morillo R, Hobohm L, Keller K, Kurnicka K, Kostrubiec M, Wachter R, Hasenfuß G, Konstantinides S, Lankeit M.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702037. doi: 10.1183/13993003.02037-2017. Print 2018 Apr.

47.

[Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine].

Wachter R, Gröschel K.

Internist (Berl). 2018 Mar;59(3):241-251. doi: 10.1007/s00108-018-0382-9. Review. German.

PMID:
29459990
48.

Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany.

Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S.

Postgrad Med. 2018 Apr;130(3):308-316. doi: 10.1080/00325481.2018.1442090. Epub 2018 Feb 28.

PMID:
29446691
49.

RAF2 is a RuBisCO assembly factor in Arabidopsis thaliana.

Fristedt R, Hu C, Wheatley N, Roy LM, Wachter RM, Savage L, Harbinson J, Kramer DM, Merchant SS, Yeates T, Croce R.

Plant J. 2018 Apr;94(1):146-156. doi: 10.1111/tpj.13849. Epub 2018 Mar 12.

50.

Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study.

Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A.

J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017 Feb-Mar.

Supplemental Content

Loading ...
Support Center